Aster DM Healthcare: NCLT approves Scheme of Amalgamation
The National Company Law Tribunal, Hyderabad Bench, passed a final order approving the Scheme of Amalgamation. The company made formal disclosure to the National Stock Exchange on 19 June 2026. The specific counterparty entity, share swap ratio, and effective date have not been disclosed in publicly available sources as of the announcement.
Why it mattersNCLT approval triggers the final statutory gate for amalgamation; transactional counsel must now ensure compliance with post-approval conditions and filing deadlines under the Companies Act 2013 and NCLT Rules.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Action Intimation (19 Jun 2026) · official
- NSE Listed Company Updates · official
- Aster DM Healthcare Investor Relations · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026